Evidence map›Paper›PMID 39309527›Full record

ArticleFrontiers in microbiology2024

A rhesus macaque intragastric challenge model for evaluating the safety, immunogenicity, and efficacy of live-attenuated

Nattaya Ruamsap, Rawiwan Imerbsin, Patchariya Khanijou, Siriphan Gonwong, Wilawan Oransathit, Shoshana Barnoy, Malabi M Venkatesan, Sidhartha Chaudhury, Dilara Islam

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nattaya RuamsapDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Rawiwan ImerbsinDepartment of Veterinary Medicine, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Patchariya KhanijouDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Siriphan GonwongDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Wilawan OransathitDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Shoshana BarnoyDepartment of Diarrheal Disease Research, Bacterial Disease Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.
Malabi M VenkatesanDepartment of Diarrheal Disease Research, Bacterial Disease Branch, Walter Reed Army Institute of Research, Silver Spring, MD, United States.
Sidhartha ChaudhuryDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.
Dilara IslamDepartment of Bacterial and Parasitic Diseases, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand.

Funding

NIAID NIH HHS Y01 AI004906
6 · The paper itself

Abstract

Shigellosis remains a significant global health challenge, particularly in Asia and Africa, where it is a major cause of morbidity and mortality among children. Despite the urgent need, the development of a licensed

Indexed as

live attenuated vaccinesrhesus monkeyShigella dysenteriae 1WRSd1WRSd2WRSd3WRSd4WRSd5

Identifiers

PMID39309527
PMCPMC11413625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.